lc106
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 19, 2023 (NCT06135974)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07305844 | Early Phase 1 (Phase 1) | Feb 10, 2026 | Centre for the AIDS Programme of Research in South Africa, Harvard University |
| NCT06135974 | Early Phase 1 (Phase 1) | Oct 19, 2023 | Bill and Melinda Gates Foundation, Centre for the AIDS Programme of Research in South Africa, Harvard University, Ragon Institute of MGH, MIT and Harvard |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Centre for the AIDS Programme of Research in South Africa | Government | 2 | 0 | 1 | 2023 |
| Harvard University | Academic/Hospital | 2 | 2 | 1 | 2023 |
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Ragon Institute of MGH, MIT and Harvard | Academic/Hospital | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1